Sweet-Syndrome under adjuvant Therapy with Pembrolizumab in a Patient with metastatic Melanoma

被引：0
|
作者：
Bley, L. I.
Braun, S. A.
Weishaupt, C.
机构：
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2020年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P58
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [41] Sweet syndrome in metastatic melanoma during treatment with dabrafenib and trametinib
    Scarfi, Federica
    Melotti, Barbara
    Veronesi, Giulia
    Ravaioli, Giulia Maria
    Baraldi, Carlotta
    Lambertini, Martina
    Patrizi, Annalisa
    Dika, Emi
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 (03) : E242 - E243
  • [42] Tumor Lysis Syndrome Presenting in a Patient with Metastatic Melanoma Treated with Radiation Therapy
    Dar, Lior
    Gendelman, Omer
    Amital, Howard
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2014, 16 (07): : 456 - 457
  • [43] Cytokine Release Syndrome in a Patient with metastatic Melanoma under BRAF/MEK Inhibition
    Dorschner, M.
    Thiem, A.
    Panzer, R.
    Rode, S.
    Emmert, S.
    Tietze, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 46 - 46
  • [44] AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report
    Ni, Dan
    Al Zahrani, Fatmah
    Smylie, Michael
    CASE REPORTS IN ONCOLOGY, 2019, 12 (02): : 456 - 465
  • [45] Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain-Barre Syndrome
    Cortellini, Alessio
    Parisi, Alessandro
    Fargnoli, Maria Concetta
    Cannita, Katia
    Irelli, Azzurra
    Porzio, Giampiero
    Martinazzo, Claudio
    Ficorella, Corrado
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2018, 2018
  • [46] Ipilimumab-associated Sweet syndrome in a melanoma patient
    Gormley, Rachel
    Wanat, Karolyn
    Elenitsas, Rosalie
    Giles, Julia
    McGettigan, Suzanne
    Schuchter, Lynn
    Takeshita, Junko
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (05) : E211 - E213
  • [47] Adjuvant melanoma therapy with nivolumab and pembrolizumab-a real-world experience
    Posch, C.
    Schumann, K.
    EXPERIMENTAL DERMATOLOGY, 2023, 32 (04) : E35 - E35
  • [48] PEMBROLIZUMAB FOR METASTATIC MELANOMA - ONE YEAR RESULTS OF NAMED PATIENT ACCESS PROGRAM
    Atkinson, Victoria G.
    Andelkovic, Vladimir
    Gunawan, Benjamin
    Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 117 - 117
  • [49] A case of pembrolizumab-induced severe DKA and hypothyroidism in a patient with metastatic melanoma
    Hakami, Osamah A.
    Ioana, Julia
    Ahmad, Shahzad
    Tun, Tommy Kyaw
    Sreenan, Seamus
    McDermott, John H.
    ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, 2019,
  • [50] PEMBROLIZUMAB FOR METASTATIC MELANOMA: RESULTS OF THE COMPLETE RESPONDERS ON THE NAMED PATIENT ACCESS PROGRAM
    Ladwa, R.
    Andelkovic, V.
    Atkinson, V.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 : 48 - 48
12345